Such a multi-marker testing strategy could extend beyond the diagnosis of Alzheimer’s disease. Elevated levels of NfL and GFAP have been linked to a range of neurological disorders, including ...

Four immunoassays for neurofilament light chain (NfL) demonstrate consistent performance in patients with amyotrophic lateral ...

Phosphorylated tau 217 better detected Alzheimer’s disease pathology across a range of neurodegenerative syndromes compared ...

“This is a wonderful piece of work,” said Henrik Zetterberg at the University of Gothenburg, Sweden. He was not involved in ...

neurofilament light chain (NfL), and glial fibrillary acidic protein (GFAP). Alzheimer's disease was defined as intermediate or high Alzheimer's neuropathological change (ADNC) at autopsy.

and glial fibrillary acidic protein (GFAP), which are all markers of Alzheimer’s disease. They also assessed the brain health of participants using neuroimaging data and testing cognitive function.

and glial fibrillary acidic protein (GFAP), which are all markers of Alzheimer’s disease. They also assessed the brain health of participants using neuroimaging data and testing cognitive function.

Alzheimer’s disease is associated with changes ... and glial fibrillary acidic protein (GFAP). Additionally, the study utilized proteomic analysis of 1,468 proteins using the Olink Explore ...

The study found significant changes in brain biomarkers linked to Alzheimer's disease in those who had contracted the virus. According to Medical News, scientists measured levels of beta-amyloid (Aβ40 ...